PPMD 2020 Virtual Annual Conference has ended
Back To Schedule
Friday, July 24 • 7:15pm - 8:25pm
In the Pipeline: Gene Therapy

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Gene therapy is a way to treat a disease by changing gene expression. That can be accomplished by correcting the mutation in the gene, providing a replacement copy of the mutated gene, introducing a surrogate (substitute) gene that produces a protein that can perform a similar role to the non-functional protein, or supplying genes that treat other symptoms of the disease. Gene therapy holds incredible promise in Duchenne and this panel will feature companies exploring various gene therapy approaches to treat Duchenne.

Gene Therapy Introduction by Tim Cripe, MD, PhD, FAAP (Nationwide Children's Hospital)

  • Sarepta (Louise Rodino-Klapac, PhD, Senior Vice President, Gene Therapy)
  • Pfizer (Beth Belluscio, MD-PhD, Global Clinical Lead)
  • Audentes (Fulvio Mavilio, PhD, Senior Vice President, Translational Science)
  • Solid (Joel Schneider, Ph.D., Chief Technology Officer)

Followed by discussion and Q & A

Visit the On-Demand Library to watch pre-recorded videos relevant to this session before heading into Conference:
Please submit questions ahead of our live panel discussions to comments@parentprojectmd.org.

avatar for Eric Camino, PhD (PPMD)

Eric Camino, PhD (PPMD)

Vice President, Research & Clinical Innovation, Parent Project Muscular Dystrophy

avatar for Fulvio Mavilio, PhD (Audentes)

Fulvio Mavilio, PhD (Audentes)

Senior Vice President, Translational Science, Audentes Therapeutics

Friday July 24, 2020 7:15pm - 8:25pm EDT
Live Stream